scholarly article | Q13442814 |
P356 | DOI | 10.1006/MTHE.2000.0053 |
P698 | PubMed publication ID | 10933955 |
P2093 | author name string | Groth D | |
Fuchs A | |||
Nikol S | |||
Keil O | |||
Pelisek J | |||
Rolland PH | |||
Quilici J | |||
Curth R | |||
Reszka R | |||
Armeanu S | |||
Krausz E | |||
P433 | issue | 4 | |
P304 | page(s) | 366-375 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo | |
P478 | volume | 1 |
Q42142908 | Anionic liposomal delivery system for DNA transfection |
Q45887356 | Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy |
Q92407854 | CRISPR/Cas9 Delivery Mediated with Hydroxyl-Rich Nanosystems for Gene Editing in Aorta |
Q39687314 | Comparison of transfection efficiency of nonviral gene transfer reagents |
Q64092782 | Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene |
Q36710629 | Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. |
Q34551100 | Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. |
Q24793340 | Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells |
Q40808104 | Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts |
Q30486444 | Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium |
Q36032833 | Gene therapy for the extension of vein graft patency: a review |
Q89144123 | Genome editing by natural and engineered CRISPR-associated nucleases |
Q50990560 | In vivo transfection rat small intestine K-cell with pGIP/Ins plasmid by DOTAP liposome. |
Q36052188 | Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery |
Q50458420 | Inhibition of restenosis formation without compromising reendothelialization as a potential solution to thrombosis following angioplasty? |
Q40630019 | Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs |
Q42440466 | Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo |
Q28220309 | Nanoparticulate carriers for the treatment of coronary restenosis |
Q34203043 | Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis |
Q39135338 | Non-viral transfection methods optimized for gene delivery to a lung cancer cell line |
Q34565066 | Nonviral gene transfer strategies for the vasculature |
Q30431522 | Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals |
Q39628648 | Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes |
Q37002661 | Polymers for DNA delivery. |
Q34804863 | Prospects for cationic polymers in gene and oligonucleotide therapy against cancer |
Q40682528 | Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors |
Q31048758 | Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery |
Q46024297 | Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery. |
Q40542525 | Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells |
Q36474300 | Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells. |
Q44431155 | Transfection of normal primary human skeletal myoblasts with p21 and p57 antisense oligonucleotides to improve their proliferation: a first step towards an alternative molecular therapy approach of Duchenne muscular dystrophy |
Q44072293 | Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA. |
Q34518719 | Vehicles for oligonucleotide delivery to tumours |
Search more.